Abstract Purpose of Review Cryopreservation and its associated freezing and thawing
procedures–short “freeze-thawing”–are among the final steps in economically viable …

Mesenchymal stem cells (MSCs) hold many advantages over embryonic stem cells (ESCs)
and other somatic cells in clinical applications. MSCs are multipotent cells with strong …

Mesenchymal stem cells (MSCs) represent an invaluable asset for the field of cell therapy.
Human Bone marrow-derived MSCs (hBM-MSCs) are one of the most commonly used cell …

The field of cellular therapeutics has immense potential, affording an exciting array of
applications in unmet medical needs. One of several key issues is an emphasis on getting …

The commercial and clinical development of cellular therapy products will invariably require
cryopreservation and frozen storage of cellular starting materials, intermediates and/or final …

Hematopoietic stem cell (HSC) therapy is widely used to treat a growing number of
hematological and non-hematological diseases. Cryopreservation of HSCs allows for cells …

Originally isolated from bone marrow, mesenchymal stromal cells (MSCs) have since been
obtained from various fetal and post-natal tissues and are the focus of an increasing number …

Cryopreservation is a key enabling technology in regenerative medicine that provides stable
and secure extended cell storage for primary tissue isolates and constructs and prepared …

Mesenchymal stromal cells (MSCs) harbor great therapeutic potential for numerous
diseases. From early clinical trials, success and failure analysis, bench-to-bedside and back …

Cryopreservation is the application of low temperatures to preserve the structural and
functional integrity of cells and tissues. Conventional cooling protocols allow ice to form and …